We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

At-Home Blood Collection Devices Market: Growth, Size, Share, and Trends

Report Code MD 9125
Published in Aug, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

At-Home Blood Collection Devices Market by Product (Lancets, DBS Kits), Sample Type (Liquid, Dried), Collection Method (Push-button, Laser), Device Type (Self, Professional), Application (Diagnostics, Screening, Clinical Trials) - Global Forecast to 2029

Overview

The at-home blood collection devices market is valued at USD 93.5 million in 2024 and is anticipated to reach USD 135.0 million by 2029, with a CAGR of 7.6% over the forecast period of 2024 to 2029. There are several drivers of the market's growth. Technological innovations are minimizing the pain associated with these devices, making them easy to use, and less invasive for consumers, with new technologies such as bladeless or needle-free sampling. Greater awareness among consumers and more emphasis on proactively managing their health are also creating demand, as consumers seek easy ways to monitor their health. Regulatory approvals and the introduction of new standards are enhancing the safety and efficiency of these devices, enhancing consumer confidence. Several companies are also lowering costs, making these devices accessible to more consumers.

At-Home Blood Collection Devices Market– Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the At-Home Blood Collection Devices Market

Asia Pacific

The Asia Pacific market is expected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and growing initiatives to promote the use of at-home blood collection technologies.

The growth of this market is driven by the increasing prevalence & incidence of diabetes and continuous technological advancements.

Preventive health is a key factor driving the use of at-home blood collection devices, as they enable individuals to monitor their health regularly and identify potential issues early, promoting proactive care and disease prevention.

The Asia Pacific at-home blood collection devices market is expected to be worth USD 34.1 million by 2029, growing at a CAGR of 9.8% during the forecast period.

Regulatory approval and partnerships were the most widely adopted growth strategies by market players.

Global At-Home Blood Collection Devices Market Dynamics

DRIVER: Rising burden of chronic disorders and life-style-related health conditions

The demand for at-home blood collection devices will clearly increase with the increase in chronic illnesses and lifestyle disorders. Some important biomarkers like blood glucose, cholesterol, and inflammatory markers need to be monitored regularly to control the chronic diseases like diabetes, cardiovascular diseases, and hypertension. At-home blood collection devices provide an easy, convenient way for people to frequently check these health metrics without having to visit health centers many times. This is particularly very useful for patients with long-term conditions, in that it allows one to fit monitoring easily into their daily routine since they require frequent health checks to minimize risks and effectively handle the conditions. Moreover, it is the guarantee of privacy and comfort during home testing that attracts more and more people who seek to manage their lives in a more personalized and proactive way toward healthcare.

RESTRAINT: Uncontrolled use of products for blood collection at home

There is a huge problem of lack of regulation around certain products used for blood collection at home. Some laboratories bypass this by using unapproved products for the sake of convenience. These products, including tubes, needles, syringes, and certain lancets, are designed for clinical use where sterilization and disposal are guaranteed. They are not meant for domestic use, and their use outside their intended environments presents serious health hazards. In this way, uncontrolled practice affects the standards and points out the serious gap in the present regulatory framework.

 

OPPORTUNITY: Growth opportunities in emerging economies

The key players in the at-home blood collection devices market are expected to find growth opportunities in developing economies such as India, Brazil, and Mexico. This has been attributed to a large patient population, high prevalence of diseases, improved healthcare infrastructure, rising disposable income, and increasing medical tourism in these nations. On top of the factors discussed above, the Asia Pacific has risen to the surface as an adaptive and business-friendly hub due to less stringent regulations.Most of the players concentrate on emerging markets, as the US and European markets are saturated. The large investments in research related to healthcare and life sciences in emerging markets act as a significant factor in upgrading the infrastructure of laboratories of such countries.

CHALLENGE: Low access to microsampling devices in resource-limited settings

One of the major restraints for the microsampling devices market is the non-accessibility of at-home blood collection devices in resource-limited settings. In spite of increasing demand for at-home blood collection devices, amplified by their technological advances, a raft of factors restrains their widespread adoption in developing or resource-limited countries. In many resource-limited settings, supply chains for these devices are not well established, and this has been associated with irregularity and delays in reaching the end users. Another major barrier is lack of awareness and education among healthcare professionals and the general populace on the benefits and usage of microsampling devices.

Global At-Home Blood Collection Devices Market Ecosystem Analysis

The at-home blood collection devices market functions within a dynamic ecosystem that encompasses multiple types of products such as fingerstick blood collection kits, dried blood spot collection kits, and lancets meant for user-friendly, minimally invasive sampling. Companies make an effort to optimize the devices for safety and precision while distributors are third-party vendors and e-commerce websites that make accessibility easier. Stakeholders are primarily end users of convenient health monitoring, healthcare providers who use remote diagnostics, investors who finance technology development, and regulatory agencies which ensure safety and quality.

At-Home Blood Collection Devices Market Ecosystem
 

“Fingerstick held the largest share of the at-home blood collection devices market in 2023, by collection method.”

The segmentation of the at-home blood collection devices market based on the method of collection includes fingerstick, push-button, and others. In 2023, the fingerstick segment captured the largest share of the at-home blood collection devices market. Fingerstick devices have a non-complex and simple user interface and require minimum training. Users can collect the blood on their own without professional guidance. These factors make frequent monitoring and testing easy at home. As a result, fingerstick devices dominate the at-home blood collection devices market.

“Self-collection devices segment accounted for the largest share of the market in 2023, by device type.”

Based on device type, the at-home blood collection devices market is categorized as self-collection and professional collection devices. The self-collection devices segment held the largest share in the at-home blood collection devices market in 2023. Due to increasing awareness about preventive healthcare and regular health monitoring, demand for self-collection devices has risen. Many prefer the convenience of self-monitoring of health. Growth in this segment of the market is majorly driven by the rising trends of diabetes and other lifestyle diseases.

“Health screening & preventive health segment dominated the at-home blood collection devices market in 2023, based on application.”

The segmentation of the at-home blood collection devices market on the basis of applications includes health screening & preventive health, disease diagnostics, clinical trials & research, and other applications. The health screening & preventive health segment dominated a major share in the at-home blood collection devices market in 2023. Rising demand for active health management and consumer awareness is fueling the growth of this segment. With a growing number of chronic and lifestyle disorders, there is greater emphasis on preventive healthcare. Home blood sampling devices enable constant monitoring of critical health parameters such as blood glucose and lipid levels, which lowers the risk of complications by ensuring ongoing disease control. Screening on a regular basis can detect potential problems before they turn serious. Home blood collection devices simplify self-sampling and make it convenient for individuals to sustain preventive health habits and ensure one's health condition is being tracked continuously.

North America region holds the largest share of the At-Home Blood Collection Devices Market.

The at-home blood collection devices market has been divided into six main geographical regions: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC countries. In 2023, it is anticipated that North America will be at the forefront of the market. The infrastructures in North America, essentially the US and Canada are very developed for diagnosis, treatment, and research pertaining to chronic disorders. This kind of set-up would facilitate easy adoption of new technologies like at-home blood collection devices.

 
 
At-Home Blood Collection Devices Market Region

Recent Developments of At-Home Blood Collection Devices Market

  • In February 2025, Tasso Inc. (US) and ARUP Laboratories (US) entered into a partnership to develop and operationalize high-quality, at-home, blood testing services to support clinical research. This partnership will combine Tasso’s clinical grade blood collection solutions and ARUP’s renowned testing capabilities to streamline and accelerate decentralized clinical research.
  • In November 2024, Capitainer (Sweden) launched the Capitainer SEP10 sampling card, which collects separated blood from a simple finger prick, generating a plasma-like sample without requiring a centrifuge. It enables at-home testing for substances that cannot be measured from whole blood, expanding access to diagnostic capabilities in previously challenging settings.
  • In June 2024, Lindus Health and Tasso, Inc. collaborated to reduce patient burden in clinical trials requiring blood collection. As per the collaboration, Lindus Health will adopt Tasso’s painless remote blood collection technology for sponsors seeking simple, cost-effective blood collection during their clinical trials. This innovative method allows participants to collect blood samples at home, eliminating the need for a mobile phlebotomist or nurse.
  • In November 2023, Randox Health, a provider of at-home and in-clinic health tests as part of Randox and Tasso, partnered to offer at-home healthcare diagnostic testing powered by Tasso’s innovative blood collection technology.
  • In October 2023, YourBio Health, Inc. (US) received further regulatory approval for its TAP Micro Select blood collection device with certification for CE Marking.
  • In January 2023, Capitainer collaborated with AstraZeneca. AstraZeneca R&D Gothenburg will use a novel device from Capitainer to develop protocols for biomarkers relevant to AstraZeneca’s clinical drug programs. The collaboration seeks to establish protocols for biomarkers pertinent to AstraZeneca’s clinical drug programs, utilizing Capitainer’s innovative self-sampling product that delivers cell-free blood. This partnership enables the implementation of new, patient-centric sampling solutions.

Key Market Players

Want to explore hidden markets that can drive new revenue in At-Home Blood Collection Devices Market?

Scope of the Report

Report Attribute Details
Market size available for years 2022–2029
Base year considered 2023
Forecast period 2024–2029
Forecast units Value (USD)
Segments Covered Product, collection method, sample type, usability, device type, and application
Geographies covered North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries

 

Key Questions Addressed by the Report

What are the recent trends affecting the at-home blood collection devices market?
Recent trends affecting the at-home blood collection devices market are the increasing chronic disease burden, exploration of new applications beyond disease diagnostics and preventive health, and increasing health awareness and the demand for proactive health management-related products.
What are the major types of at-home blood collection devices products?
Based on product, the at-home blood collection devices market is segmented into lancets, dried blood spot collection kits, finger stick blood collection kits, and other products. The lancets segment accounted for the largest share in 2023 due to the increasing prevalence of diabetes and the frequent need for blood glucose testing. Lancets are also cost-effective, making them accessible to a wider range of consumers.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the At-Home Blood Collection Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
31
EXECUTIVE SUMMARY
44
PREMIUM INSIGHTS
50
MARKET OVERVIEW
55
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing burden of chronic disorders and lifestyle-related health conditions
    - Increasing prevalence of infectious diseases
    - Rising geriatric population and incidence of age-associated diseases
    - Rising demand for painless devices and growing technological advancements
    RESTRAINTS
    - Unregulated use of products for at-home blood collection
    - Pricing pressure owing to reimbursement cuts and budget constraints
    OPPORTUNITIES
    - Growth opportunities in emerging economies
    CHALLENGES
    - Inadequate access to microsampling devices in resource-limited areas
  • 5.3 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF LANCETS
    AVERAGE SELLING PRICE OF AT-HOME BLOOD COLLECTION LANCETS, BY KEY PLAYER, 2022–2024
    AVERAGE SELLING PRICE OF AT-HOME BLOOD COLLECTION DEVICES, BY COUNTRY, 2022–2024
  • 5.4 PATENT ANALYSIS
    LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    AT-HOME BLOOD COLLECTION DEVICES MARKET: ROLE IN ECOSYSTEM
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Lancets
    COMPLEMENTARY TECHNOLOGIES
    - Dried blood spot collection
    ADJACENT TECHNOLOGIES
    - Laser lancets
  • 5.10 TRADE ANALYSIS
    TRADE ANALYSIS FOR LANCETS, CANNULAS, AND CATHETERS
    IMPORT DATA
    EXPORT DATA
  • 5.11 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
  • 5.14 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.16 INVESTMENT & FUNDING SCENARIO
  • 5.17 CASE STUDY ANALYSIS
    CASE STUDY 1: ASSESSING DIAGNOSTIC ACCURACY OF VOLUMETRIC ABSORPTIVE MICROSAMPLING COMPARED TO GOLD STANDARD METHOD
    CASE STUDY 2: EVALUATING VOLUMETRIC FINGER-PRICK SAMPLING FOR MONITORING TACROLIMUS, CREATININE, AND HEMOGLOBIN IN KIDNEY TRANSPLANT RECIPIENTS
    CASE STUDY 3: ASSESSING ACCURACY OF SELF-SAMPLING FOR INFLAMMATION AND AUTOANTIBODIES IN RHEUMATOID ARTHRITIS
  • 5.18 IMPACT OF AI ON AT-HOME BLOOD COLLECTION DEVICES MARKET
    MARKET POTENTIAL OF AI IN AT-HOME BLOOD COLLECTION DEVICES APPLICATIONS
    AI USE CASES
    FUTURE OF AI IN AT-HOME BLOOD COLLECTION DEVICES MARKET
AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT
99
  • 6.1 INTRODUCTION
  • 6.2 LANCETS
    HIGH AFFORDABILITY AND FREQUENT USE TO DRIVE UPTAKE OF LANCETS
  • 6.3 DRIED BLOOD SPOT COLLECTION KITS
    SUPPORT FOR SHORT-TERM STORAGE TO DRIVE MARKET
  • 6.4 FINGERSTICK BLOOD COLLECTION KITS
    DEMAND FOR PAINLESS TECHNOLOGIES TO HAMPER MARKET GROWTH
  • 6.5 OTHER PRODUCTS
AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE
113
  • 7.1 INTRODUCTION
    PRIMARY NOTES
  • 7.2 LIQUID BLOOD SAMPLES
    FAVORABLE REGULATORY AND INVESTMENT LANDSCAPES TO DRIVE ADOPTION
  • 7.3 DRIED BLOOD SAMPLES
    EASY COLLECTION AND REDUCED REQUIREMENT FOR COLD STORAGE TO SUPPORT UPTAKE OF DRIED BLOOD-BASED DEVICES
AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD
123
  • 8.1 INTRODUCTION
  • 8.2 FINGERSTICK SAMPLE COLLECTION
    HIGH AFFORDABILITY AND ACCESSIBILITY TO DRIVE MARKET
  • 8.3 PUSH-BUTTON SAMPLE COLLECTION
    CONSISTENCY AND RELIABILITY TO SUPPORT HOME-USE ADOPTION
  • 8.4 OTHER SAMPLE COLLECTION METHODS
AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE
134
  • 9.1 INTRODUCTION
  • 9.2 SELF-COLLECTION DEVICES
    INCREASED PRIVACY AND CONFIDENTIALITY OF SELF-COLLECTION DEVICES TO DRIVE MARKET
  • 9.3 PROFESSIONAL COLLECTION DEVICES
    GROWING AWARENESS AND USAGE OF SELF-COLLECTION DEVICES TO HINDER ADOPTION
AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY
142
  • 10.1 INTRODUCTION
  • 10.2 SINGLE-USE BLOOD COLLECTION DEVICES
    INCREASED AFFORDABILITY OF SINGLE-USE DEVICES TO DRIVE ADOPTION
  • 10.3 REUSABLE BLOOD COLLECTION DEVICES
    NEED FOR PAINLESS TECHNOLOGIES TO PROPEL UPTAKE
AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION
150
  • 11.1 INTRODUCTION
  • 11.2 HEALTH SCREENING & PREVENTIVE HEALTH
    GROWING AWARENESS OF REGULAR HEALTH ASSESSMENTS TO FUEL MARKET GROWTH
  • 11.3 DISEASE DIAGNOSTICS
    INCREASING DEMAND FOR EARLY DISEASE DETECTION TO DRIVE MARKET
  • 11.4 CLINICAL TRIALS & RESEARCH
    NEED FOR COMPREHENSIVE & STANDARDIZED RESEARCH FINDINGS TO PROPEL MARKET GROWTH
  • 11.5 OTHER APPLICATIONS
AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION
164
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Advanced infrastructure and high healthcare expenditure to drive market
    CANADA
    - Rising prevalence of kidney diseases to propel demand
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing healthcare expenditure to propel market
    UK
    - Increasing prevalence of lifestyle diseases to drive market
    FRANCE
    - Rising R&D expenditure to provide growth opportunities
    ITALY
    - Growing diabetes prevalence to sustain demand for testing
    SPAIN
    - Growth in elderly demographics in Spain to propel market
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - China to hold largest share of APAC market
    JAPAN
    - Well-established healthcare system to support market
    INDIA
    - Large patient population and rising prevalence of chronic diseases to drive market
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Brazil to dominate LATAM market
    MEXICO
    - Rising prevalence of chronic diseases to drive market
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.7 GCC COUNTRIES
    INFRASTRUCTURAL DEVELOPMENT AND GROWING DISEASE INCIDENCE TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
231
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN AT-HOME BLOOD COLLECTION DEVICES MARKET
  • 13.3 REVENUE ANALYSIS, 2021–2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Product footprint
    - Application footprint
    - Sample type footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
  • 13.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    DETAILED LIST OF KEY STARTUPS/SMES
    COMPETITIVE BENCHMARKING OF STARTUPS/SMES
    - Competitive benchmarking of startups/SMEs, by sample type and application
    - Competitive benchmarking of startups/SMEs, by region
  • 13.8 COMPANY VALUATION & FINANCIAL METRICS
  • 13.9 BRAND/PRODUCT COMPARISON
    SARA HEALTHCARE
    OWEN MUMFORD
    A. MENARINI DIAGNOSTICS S.R.L
    PHOENIX HEALTHCARE SOLUTIONS, LLC
  • 13.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
250
  • 14.1 KEY PLAYERS
    TASSO, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    TRAJAN GROUP HOLDINGS LIMITED
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    YOURBIO HEALTH, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CAPITAINER
    - Business overview
    - Products offered
    - Recent developments
    A. MENARINI DIAGNOSTICS S.R.L (MENARINI GROUP)
    - Business overview
    - Products offered
    R-BIOPHARM AG
    - Business overview
    - Products offered
    SUSSEX PATHOLOGY LIMITED
    - Business overview
    - Products offered
    - Recent developments
    IMMUNOSERV
    - Business overview
    - Products offered
    LABONOVUM
    - Business overview
    - Products offered
    ALPHA LABORATORIES
    - Business overview
    - Products offered
    LIPOMIC HEALTHCARE
    - Business overview
    - Products offered
    TRI-TECH FORENSICS
    - Business overview
    - Products offered
  • 14.2 OTHER PLAYERS
    RDA SPOT INC
    SPOT ON SCIENCES
    PANOHEALTH
    LAMEDITECH
    SARA HEALTHCARE
    OWEN MUMFORD LTD
    REDDROP DX, INC.
    ADVACARE PHARMA
    NAULAKHA INDUSTRIES
    PHOENIX HEALTHCARE SOLUTIONS, LLC
    DRAWBRIDGE HEALTH, INC.
APPENDIX
279
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 GLOBAL HIV DATA (2020 VS. 2022 VS. 2023)
  • TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION (2022 VS. 2030 VS. 2050)
  • TABLE 3 AVERAGE SELLING PRICE OF LANCETS, 2022–2024
  • TABLE 4 AVERAGE SELLING PRICE OF AT-HOME BLOOD COLLECTION LANCETS, BY KEY PLAYERS, 2022–2024
  • TABLE 5 AVERAGE SELLING PRICE TREND OF AT-HOME BLOOD COLLECTION DEVICES, BY COUNTRY, 2022–2024
  • TABLE 6 AT-HOME BLOOD COLLECTION DEVICES MARKET: LIST OF MAJOR PATENTS, 2022–2024
  • TABLE 7 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019–2023 (USD MILLION)
  • TABLE 8 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019–2023 (USD MILLION)
  • TABLE 9 AT-HOME BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF AT-HOME BLOOD COLLECTION DEVICES (%)
  • TABLE 11 KEY BUYING CRITERIA FOR AT-HOME BLOOD COLLECTION DEVICES
  • TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 13 EUROPE: CLASSIFICATION OF DEVICES
  • TABLE 14 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 AT-HOME BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS IN 2025–2026
  • TABLE 21 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 22 COMMERCIALLY AVAILABLE LANCETS, BY COMPANY
  • TABLE 23 LANCETS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 NORTH AMERICA: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 25 EUROPE: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 ASIA PACIFIC: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 LATIN AMERICA: LANCETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 COMMERCIALLY AVAILABLE DBS COLLECTION KITS, BY COMPANY
  • TABLE 29 DBS COLLECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 NORTH AMERICA: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 EUROPE: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 LATIN AMERICA: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 FINGERSTICK BLOOD COLLECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 NORTH AMERICA: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 EUROPE: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 LATIN AMERICA: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 EUROPE: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, 2022–2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, 2022–2029 (USD MILLION)
  • TABLE 44 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 45 LIQUID BLOOD SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 46 AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 NORTH AMERICA: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 EUROPE: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 LATIN AMERICA: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 DRIED BLOOD SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 52 COMPARATIVE ANALYSIS: DRIED BLOOD SPOT VS. CONVENTIONAL SAMPLES (WHOLE BLOOD, SERUM, AND PLASMA)
  • TABLE 53 AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 NORTH AMERICA: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 EUROPE: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 LATIN AMERICA: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 59 FINGERSTICK SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 60 AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 EUROPE: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 LATIN AMERICA: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 PUSH-BUTTON SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 66 AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 EUROPE: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 LATIN AMERICA: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 77 AT-HOME SELF-COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 EUROPE: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 LATIN AMERICA: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 EUROPE: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 LATIN AMERICA: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 88 SINGLE-USE DEVICES: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 89 SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 REUSABLE BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 LATIN AMERICA: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 100 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 106 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: MACROECONOMIC INDICATORS FOR AT-HOME BLOOD COLLECTION DEVICES MARKET
  • TABLE 122 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 129 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 130 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 132 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 134 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 135 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 136 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 138 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 140 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 141 EUROPE: MACROECONOMIC INDICATORS FOR AT-HOME BLOOD COLLECTION DEVICES MARKET
  • TABLE 142 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 144 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 146 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 148 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 149 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 150 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 152 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 154 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 155 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 156 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 158 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 160 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 161 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 162 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 164 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 166 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 167 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 168 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 170 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 172 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 173 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 174 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 176 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 178 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 179 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 180 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 182 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 184 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: MACROECONOMIC INDICATORS FOR AT-HOME BLOOD COLLECTION DEVICES MARKET
  • TABLE 186 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 192 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 193 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 194 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 196 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 198 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 199 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 200 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 202 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 204 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 205 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 206 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 208 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 210 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 216 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: MACROECONOMIC INDICATORS FOR AT-HOME BLOOD COLLECTION DEVICES MARKET
  • TABLE 218 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 222 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 225 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 226 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 228 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 230 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 231 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 232 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 234 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 236 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 237 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 238 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 240 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 242 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 243 MIDDLE EAST & AFRICA: MACROINDICATORS FOR AT-HOME BLOOD COLLECTION DEVICES MARKET
  • TABLE 244 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 245 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 247 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 249 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 250 GCC COUNTRIES: MACROECONOMIC INDICATORS FOR AT-HOME BLOOD COLLECTION DEVICES MARKET
  • TABLE 251 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022–2029 (USD MILLION)
  • TABLE 254 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022–2029 (USD MILLION)
  • TABLE 256 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 257 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AT-HOME BLOOD COLLECTION DEVICES MARKET, JANUARY 2021–FEBRUARY 2025
  • TABLE 258 AT-HOME BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 259 AT-HOME BLOOD COLLECTION DEVICES MARKET: REGION FOOTPRINT
  • TABLE 260 AT-HOME BLOOD COLLECTION DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 261 AT-HOME BLOOD COLLECTION DEVICES MARKET: APPLICATION FOOTPRINT
  • TABLE 262 AT-HOME BLOOD COLLECTION DEVICES MARKET: SAMPLE TYPE FOOTPRINT
  • TABLE 263 AT-HOME BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 264 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY SAMPLE TYPE AND APPLICATION
  • TABLE 265 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
  • TABLE 266 AT-HOME BLOOD COLLECTION DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 267 AT-HOME BLOOD COLLECTION DEVICES MARKET: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 268 AT-HOME BLOOD COLLECTION DEVICES MARKET: EXPANSIONS, JANUARY 2021–FEBRUARY 2025
  • TABLE 269 AT-HOME BLOOD COLLECTION DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021– FEBRUARY 2025
  • TABLE 270 TASSO, INC.: COMPANY OVERVIEW
  • TABLE 271 TASSO, INC.: PRODUCTS OFFERED
  • TABLE 272 TASSO, INC.: PRODUCT APPROVALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 273 TASSO, INC.: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 274 TRAJAN GROUP HOLDINGS LIMITED: COMPANY OVERVIEW
  • TABLE 275 TRAJAN GROUP HOLDINGS LIMITED: PRODUCTS OFFERED
  • TABLE 276 TRAJAN GROUP HOLDINGS LIMITED: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 277 TRAJAN GROUP HOLDINGS LIMITED: OTHER DEVELOPMENTS, JANUARY 2021–FEBRUARY 2025
  • TABLE 278 YOURBIO HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 279 YOURBIO HEALTH, INC.: PRODUCTS OFFERED
  • TABLE 280 YOURBIO HEALTH, INC.: PRODUCT APPROVALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 281 YOURBIO HEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2021–FEBRUARY 2025
  • TABLE 282 CAPITAINER: COMPANY OVERVIEW
  • TABLE 283 CAPITAINER: PRODUCTS OFFERED
  • TABLE 284 CAPITAINER: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025
  • TABLE 285 CAPITAINER: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 286 CAPITAINER: EXPANSIONS, JANUARY 2021–FEBRUARY 2025
  • TABLE 287 A. MENARINI DIAGNOSTICS S.R.L.: COMPANY OVERVIEW
  • TABLE 288 A. MENARINI DIAGNOSTICS S.R.L.: PRODUCTS OFFERED
  • TABLE 289 R-BIOPHARM AG: COMPANY OVERVIEW
  • TABLE 290 R-BIOPHARM AG: PRODUCTS OFFERED
  • TABLE 291 SUSSEX PATHOLOGY LIMITED: COMPANY OVERVIEW
  • TABLE 292 SUSSEX PATHOLOGY LIMITED: PRODUCTS OFFERED
  • TABLE 293 SUSSEX PATHOLOGY LIMITED: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 294 IMMUNOSERV: COMPANY OVERVIEW
  • TABLE 295 IMMUNOSERV: PRODUCTS OFFERED
  • TABLE 296 LABONOVUM: COMPANY OVERVIEW
  • TABLE 297 LABONOVUM: PRODUCTS OFFERED
  • TABLE 298 ALPHA LABORATORIES: COMPANY OVERVIEW
  • TABLE 299 ALPHA LABORATORIES: PRODUCTS OFFERED
  • TABLE 300 LIPOMIC HEALTHCARE: COMPANY OVERVIEW
  • TABLE 301 LIPOMIC HEALTHCARE: PRODUCTS OFFERED
  • TABLE 302 TRI-TECH FORENSICS: COMPANY OVERVIEW
  • TABLE 303 TRI-TECH FORENSICS: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 AT-HOME BLOOD COLLECTION DEVICES MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 AT-HOME BLOOD COLLECTION DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND LIFESTYLE-RELATED DISORDERS TO SUPPORT MARKET GROWTH
  • FIGURE 16 LANCETS TO DOMINATE MARKET TILL 2029
  • FIGURE 17 LIQUID BLOOD SAMPLES TO HOLD LARGEST MARKET SHARE
  • FIGURE 18 FINGERSTICK AND PUSH-BUTTON METHODS TO HOLD LARGER SHARES
  • FIGURE 19 SELF-COLLECTION DEVICES TO DOMINATE MARKET IN 2029
  • FIGURE 20 SINGE-USE BLOOD COLLECTION DEVICES SEGMENT TO HOLD LARGER SHARE
  • FIGURE 21 HEALTH SCREENING & PREVENTIVE HEALTH TO ACCOUNT FOR LARGER MARKET SHARE TILL 2029
  • FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 AT-HOME BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION INDIVIDUALS)
  • FIGURE 25 HEART AND CIRCULATORY DISEASE PREVALENCE: GLOBAL STATISTICS (2021)
  • FIGURE 26 AVERAGE SELLING PRICE OF LASER LANCETS, 2024
  • FIGURE 27 PATENT ANALYSIS FOR MICROSAMPLING DEVICES (JANUARY 2014–DECEMBER 2024)
  • FIGURE 28 VALUE CHAIN ANALYSIS OF AT-HOME BLOOD COLLECTION DEVICES MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 29 AT-HOME BLOOD COLLECTION DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 AT-HOME BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 32 AT-HOME BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF AT-HOME BLOOD COLLECTION DEVICES
  • FIGURE 34 KEY BUYING CRITERIA FOR AT-HOME BLOOD COLLECTION DEVICES
  • FIGURE 35 US: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 36 CANADA: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 37 JAPAN: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 38 INDIA: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 39 BRAZIL: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 40 AT-HOME BLOOD COLLECTION DEVICES MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 41 MARKET POTENTIAL OF AI IN AT-HOME BLOOD COLLECTION DEVICES APPLICATIONS
  • FIGURE 42 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET SNAPSHOT
  • FIGURE 43 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET SNAPSHOT
  • FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AT-HOME BLOOD COLLECTION DEVICES MARKET (2023)
  • FIGURE 45 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 46 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 47 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 48 AT-HOME BLOOD COLLECTION DEVICES MARKET: BRAND COMPARISON FOR LANCETS
  • FIGURE 49 TRAJAN GROUP HOLDINGS LIMITED: COMPANY SNAPSHOT (2024)

 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players, the competitive landscape of the at-home blood collection devices market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Breakdown Of Primary Participants:

At-home blood collection Devices Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

YourBio Health

Sales Executive

Capitainer

Sales Executive

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the at-home blood collection devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the at-home blood collection devices market have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global At-home blood collection Devices Market Size: Bottom Up Approach

At-home blood collection Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

At-home blood collection devices are tools designed to allow individuals or professionals to collect small blood samples from home care settings. These devices are easy to use and minimally invasive, making them suitable for various applications.

Key Stakeholders

  • Senior Management
  • End User
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the at-home blood collection devices market, by product, sample type, collection method, device type, usability, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments in six regions: North America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and GCC countries
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as acquisitions, collaborations, partnerships, agreements, and product launches & approvals in the at-home blood collection devices market
  • To benchmark players within the at-home blood collection devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available Customizations

MarketsandMarkets offers the following customizations for this market report.

Country Information

  • Additional country-level analysis of the at-home blood collection devices market

Company profiles

  • Additional five company profiles of players operating in the at-home blood collection devices market.

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the at-home blood collection devices market

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in At-Home Blood Collection Devices Market

DMCA.com Protection Status